Add Formweb to your mobile device
Search results for:
nevirapine
nevirapine
- Hazardous Drugs Handling Guide (Group 2: Non-Antineoplastic)
- Cell Status NFISA
- * Non-Formulary *
Brand names: VIRAMUNE, VIRAMUNE XR
| Form | Strength | |
|---|---|---|
| TABLET, EXTENDED RELEASE, ORAL | 400 mg | |
| TABLET, ORAL | 200 mg |
Last updated: Jan. 26, 2024
- Black Box Warning: Hepatotoxicity; dermal reactions; patient monitoring